CPDC helps researchers at academic institutions and private companies move their innovative discoveries in molecular imaging probes from the lab to the clinic and into the global market. We provide a unique combination of expertise and infrastructure to identify and advance promising probe technologies and ensure commercialization of Canadian probe discoveries.
What are Molecular Imaging Probes?
Molecular imaging probes enable physicians to non-invasively see the molecular processes that lead to disease. This rapidly advancing area of science and patient care is opening a new era of personalized medicine where physicians can use medical imaging to provide patients with earlier detection of disease, more accurate diagnosis and tailored treatment.
CPDC: It begins with one
CPDC provides the resources and expertise to bring revolutionary advancements in probe technology to market. And like all revolutions, it begins with one – one innovative idea, one unwavering commitment, and one patient in need. Watch our video to learn how CPDC is impacting commercialization and health care in Canada.